These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11800643)

  • 1. Down-regulation of Fas expression in the lymph nodes of patients infected with human immunodeficiency virus.
    Wang L; Adegboyega PA
    Arch Pathol Lab Med; 2002 Jan; 126(1):28-32. PubMed ID: 11800643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes.
    Badley AD; McElhinny JA; Leibson PJ; Lynch DH; Alderson MR; Paya CV
    J Virol; 1996 Jan; 70(1):199-206. PubMed ID: 8523526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cysteine protease inhibitor prevents activation-induced T-cell apoptosis and death of peripheral blood cells from human immunodeficiency virus-infected individuals by inhibiting upregulation of Fas ligand.
    Yang Y; Liu ZH; Ware CF; Ashwell JD
    Blood; 1997 Jan; 89(2):550-7. PubMed ID: 9002958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas-Fas ligand.
    Noraz N; Gozlan J; Corbeil J; Brunner T; Spector SA
    AIDS; 1997 Nov; 11(14):1671-80. PubMed ID: 9386801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
    Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
    J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated expression of Fas and Fas ligand in brain through the spectrum of HIV-1 infection.
    Elovaara I; Sabri F; Gray F; Alafuzoff I; Chiodi F
    Acta Neuropathol; 1999 Oct; 98(4):355-62. PubMed ID: 10502040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons.
    Hosaka N; Oyaizu N; Kaplan MH; Yagita H; Pahwa S
    J Infect Dis; 1998 Oct; 178(4):1030-9. PubMed ID: 9806031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques.
    Herbeuval JP; Nilsson J; Boasso A; Hardy AW; Vaccari M; Cecchinato V; Valeri V; Franchini G; Andersson J; Shearer GM
    AIDS; 2009 Jan; 23(1):35-40. PubMed ID: 19050384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication.
    Sloand EM; Young NS; Kumar P; Weichold FF; Sato T; Maciejewski JP
    Blood; 1997 Feb; 89(4):1357-63. PubMed ID: 9028959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells.
    Algeciras-Schimnich A; Vlahakis SR; Villasis-Keever A; Gomez T; Heppelmann CJ; Bou G; Paya CV
    AIDS; 2002 Jul; 16(11):1467-78. PubMed ID: 12131184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children.
    Bäumler CB; Böhler T; Herr I; Benner A; Krammer PH; Debatin KM
    Blood; 1996 Sep; 88(5):1741-6. PubMed ID: 8781430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals.
    Ehrhard S; Wernli M; Kaufmann G; Pantaleo G; Rizzardi GP; Gudat F; Erb P; Battegay M
    Infection; 2008 Mar; 36(2):120-9. PubMed ID: 18379725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) antigens and genome in lymph nodes of HIV-positive patients affected by persistent generalized lymphadenopathy (PGL).
    Uccini S; Monardo F; Vitolo D; Faggioni A; Gradilone A; Aglianó AM; Manzari V; Ruco LP; Baroni CD
    Am J Clin Pathol; 1989 Dec; 92(6):729-35. PubMed ID: 2556016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas/FasL interaction is not involved in apoptosis of activated CD4+ T cells upon HIV-1 infection in vitro.
    Yagi T; Sugimoto A; Tanaka M; Nagata S; Yasuda S; Yagita H; Kuriyama T; Takemori T; Tsunetsugu-Yokota Y
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):307-15. PubMed ID: 9704935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.
    Körner C; Tolksdorf F; Riesner K; Krämer B; Schulte D; Nattermann J; Rockstroh JK; Spengler U
    Antivir Ther; 2011; 16(7):1047-55. PubMed ID: 22024520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas/Fas ligand-mediated apoptosis in different cell lineages and functional compartments of human lymph nodes.
    Kokkonen TS; Karttunen TJ
    J Histochem Cytochem; 2010 Feb; 58(2):131-40. PubMed ID: 19826071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo.
    Sloand EM; Kumar PN; Kim S; Chaudhuri A; Weichold FF; Young NS
    Blood; 1999 Aug; 94(3):1021-7. PubMed ID: 10419894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas antigen expression and apoptosis of lymphocytes in macaques infected with simian immunodeficiency virus strain mac.
    Iida T; Igarashi T; Ichimura H; Kuwata T; Shimada T; Nagamachi D; Yonehara S; Imanishi J; Hayami M
    Arch Virol; 1998; 143(4):717-29. PubMed ID: 9638143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand deficiency in HIV disease.
    Sieg S; Smith D; Yildirim Z; Kaplan D
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5860-5. PubMed ID: 9159165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo analysis of Fas/FasL interactions in HIV-infected patients.
    Badley AD; Dockrell DH; Algeciras A; Ziesmer S; Landay A; Lederman MM; Connick E; Kessler H; Kuritzkes D; Lynch DH; Roche P; Yagita H; Paya CV
    J Clin Invest; 1998 Jul; 102(1):79-87. PubMed ID: 9649560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.